To compare characteristics of IXT patients undergoing part-time patching therapy and identify specific factors associated with the success of patch therapy.
Key Findings:
Treatment success defined as deviation ≤ 10 PD after patch therapy, indicating effective management.
Recurrence defined as deviation ≥ 15 PD within 1 year post-treatment success, highlighting the need for ongoing monitoring.
Factors influencing success included duration of patching and initial deviation severity, suggesting areas for targeted intervention.
Interpretation:
Part-time patching therapy can effectively reduce deviation in IXT patients, but success varies based on individual characteristics such as initial severity and treatment duration.
Limitations:
Retrospective design may introduce bias, potentially affecting the reliability of the findings.
Exclusion of patients with amblyopia and other strabismus types limits generalizability, suggesting caution in applying results broadly.
Conclusion:
Patch therapy is a viable conservative treatment for IXT, with specific factors influencing its success; further research is needed to optimize treatment protocols and explore the impact of excluded conditions.
